ECCO in Vienna was the Best Congress Ever!
ECCO in Vienna was the Best Congress Ever!
PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
Palle BAGER | Clinical Nurse Specialist / Senior researcher / Associate Professor at Aarhus University | RN, MPH, PhD | Aarhus University Hospital, Århus | AUH | Department of Hepatology and Gastroenterology
PDF) The histopathological approach to inflammatory bowel disease: A practice guide
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
European Crohn´s and Colitis Organisation - ECCO - Uncategorised
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile
NewsWINTER
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano
Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition
ECCO
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
WINTER
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
